N-[(2S)-1-[[(2S,3R)-3-hydroxy-1-[[(2S)-1-[[(2S)-4-methyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-1-oxobutan-2-yl]amino]-1-oxo-4-phenylbutan-2-yl]-5-methyl-1,2-oxazole-3-carboxamide
C37H47N5O8 — CID 155512766
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[(2S)-1-[[(2S,3R)-3-hydroxy-1-[[(2S)-1-[[(2S)-4-methyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-1-oxobutan-2-yl]amino]-1-oxo-4-phenylbutan-2-yl]-5-methyl-1,2-oxazole-3-carboxamide
N-[(2S)-1-[[(2S,3R)-3-hydroxy-1-[[(2S)-1-[[(2S)-4-methyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-1-oxobutan-2-yl]amino]-1-oxo-4-phenylbutan-2-yl]-5-methyl-1,2-oxazole-3-carboxamide (PubChem CID 155512766) has the molecular formula C37H47N5O8 and a molecular weight of 689.81 g/mol. Its IUPAC name is N-[(2S)-1-[[(2S,3R)-3-hydroxy-1-[[(2S)-1-[[(2S)-4-methyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-1-oxobutan-2-yl]amino]-1-oxo-4-phenylbutan-2-yl]-5-methyl-1,2-oxazole-3-carboxamide.
Molecular Properties
| Compound Name | N-[(2S)-1-[[(2S,3R)-3-hydroxy-1-[[(2S)-1-[[(2S)-4-methyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-1-oxobutan-2-yl]amino]-1-oxo-4-phenylbutan-2-yl]-5-methyl-1,2-oxazole-3-carboxamide |
|---|---|
| PubChem CID | 155512766 |
| Molecular Formula | C37H47N5O8 |
| Molecular Weight | 689.81 g/mol |
| Exact Mass | 689.34 |
| IUPAC Name | N-[(2S)-1-[[(2S,3R)-3-hydroxy-1-[[(2S)-1-[[(2S)-4-methyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-1-oxobutan-2-yl]amino]-1-oxo-4-phenylbutan-2-yl]-5-methyl-1,2-oxazole-3-carboxamide |
| SMILES | Cc1cc(C(=O)N[C@@H](CCc2ccccc2)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]2(C)CO2)[C@@H](C)O)no1 |
| InChI | InChI=1S/C37H47N5O8/c1-22(2)18-28(32(44)37(5)21-49-37)39-34(46)29(20-26-14-10-7-11-15-26)40-36(48)31(24(4)43)41-33(45)27(17-16-25-12-8-6-9-13-25)38-35(47)30-19-23(3)50-42-30/h6-15,19,22,24,27-29,31,43H,16-18,20-21H2,1-5H3,(H,38,47)(H,39,46)(H,40,48)(H,41,45)/t24-,27+,28+,29+,31+,37-/m1/s1 |
| InChIKey | WVFLVYXDAMUASN-CPMHCHEQSA-N |
| XLogP | 2.20 |
| TPSA | 192.26 Ų |
| H-Bond Donors | 5 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 18 |
| Heavy Atoms | 50 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 689.81 |
| LogP ≤ 5 | 2.20 |
| H-Bond Donors ≤ 5 | 5 |
| H-Bond Acceptors ≤ 10 | 9 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Three-membered_heterocycle', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155512766 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.